Related Experiment Video

Updated: Aug 19, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Management of infants with chronic lung disease of prematurity in Chile

Maria Angélica Palomino1, Mónica Morgues, Fernando Martínez

  • 1Departamento de Pediatría Norte, Facultad de Medicina, Universidad de Chile, Respiratory Unit, Roberto del Río Children's Hospital, Zañartu 1085, Independencia, Santiago, Chile. mpalomino@med.uchile.cl

Early Human Development
|March 8, 2005
PubMed

Insights

Chronic lung disease (CLD) significantly impacts preterm infants in Chile. National guidelines and home oxygen programs have improved outcomes for premature babies with CLD since 1998.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Public Health

Background:

  • Chronic lung disease (CLD) is a significant cause of death and illness in preterm infants in Chile.
  • CLD incidence in Chile ranges from 10% to 60% regionally.
  • National management guidelines for CLD post-neonatal discharge have been in place since 1998.

Purpose of the Study:

  • To summarize the current management and outcomes of chronic lung disease in preterm infants in Chile.
  • To highlight the role of national guidelines and home oxygen programs.
  • To discuss specific therapeutic interventions and preventive strategies for CLD.

Main Methods:

  • Review of national guidelines for CLD management in preterm infants.
  • Description of target oxygen saturation levels and home oxygen program.
  • Summary of specific treatments including diuretics, steroids, and bronchodilators.
  • Emphasis on Respiratory Syncytial Virus (RSV) prevention and national surveillance.

Main Results:

  • National guidelines and home oxygen programs have improved outcomes for infants with CLD.
  • Specific oxygen saturation targets are set based on postconceptional age.
  • Adverse neurological outcomes limit the use of postnatal steroids.

Conclusions:

  • Effective management of CLD in preterm infants in Chile involves adherence to national guidelines and home oxygen support.
  • Careful consideration of treatment side effects, such as neurological risks with postnatal steroids, is crucial.
  • RSV prevention is a critical component of CLD care for preterm infants.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: